Literature DB >> 22540867

Nuclear mapping of nanodrug delivery systems in dynamic cellular environments.

Ashwinkumar A Bhirde1, Ankur Kapoor, Gang Liu, Ramiro Iglesias-Bartolome, Albert Jin, Guofeng Zhang, Ruijun Xing, Seulki Lee, Richard D Leapman, J Silvio Gutkind, Xiaoyuan Chen.   

Abstract

Nanoformulations have shown great promise for delivering chemotherapeutics and hold tremendous clinical relevance. However nuclear mapping of the chemodrugs is important to predict the success of the nanoformulation. In this study fluorescence microscopy and a subcellular tracking algorithm were used to map the diffusion of chemotherapeutic drugs in cancer cells. Positively charged nanoparticles efficiently carried the chemodrug across the cell membrane. The algorithm helped map free drug and drug-loaded nanoparticles, revealing a varying nuclear diffusion pattern of the chemotherapeutics in drug-sensitive and -resistant cells in a live dynamic cellular environment. While the drug-sensitive cells showed an exponential uptake of the drug with time, resistant cells showed random and asymmetric drug distribution. Moreover nanoparticles carrying the drug remained in the perinuclear region, while the drug accumulated in the cell nuclei. The tracking approach has enabled us to predict the therapeutic success of different nanoscale formulations of doxorubicin.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22540867      PMCID: PMC3383922          DOI: 10.1021/nn300516g

Source DB:  PubMed          Journal:  ACS Nano        ISSN: 1936-0851            Impact factor:   15.881


  36 in total

1.  Doxorubicin loaded iron oxide nanoparticles overcome multidrug resistance in cancer in vitro.

Authors:  Forrest M Kievit; Freddy Y Wang; Chen Fang; Hyejung Mok; Kui Wang; John R Silber; Richard G Ellenbogen; Miqin Zhang
Journal:  J Control Release       Date:  2011-01-26       Impact factor: 9.776

Review 2.  Tumor angiogenesis: molecular pathways and therapeutic targets.

Authors:  Sara M Weis; David A Cheresh
Journal:  Nat Med       Date:  2011-11-07       Impact factor: 53.440

Review 3.  Chemotherapy and cognitive impairment: treatment options.

Authors:  J E Fardell; J Vardy; I N Johnston; G Winocur
Journal:  Clin Pharmacol Ther       Date:  2011-08-03       Impact factor: 6.875

4.  Nanomedicine: Silence the target.

Authors:  Christian Plank
Journal:  Nat Nanotechnol       Date:  2009-08-23       Impact factor: 39.213

Review 5.  Superparamagnetic iron oxide nanoparticles: diagnostic magnetic resonance imaging and potential therapeutic applications in neurooncology and central nervous system inflammatory pathologies, a review.

Authors:  Jason S Weinstein; Csanad G Varallyay; Edit Dosa; Seymur Gahramanov; Bronwyn Hamilton; William D Rooney; Leslie L Muldoon; Edward A Neuwelt
Journal:  J Cereb Blood Flow Metab       Date:  2009-09-16       Impact factor: 6.200

6.  Optimizing cancer care: is the future bright?

Authors:  P Zahedi; R De Souza; M Piquette-Miller
Journal:  Clin Pharmacol Ther       Date:  2011-09       Impact factor: 6.875

7.  Interference by doxorubicin with DNA unwinding in MCF-7 breast tumor cells.

Authors:  F A Fornari; J K Randolph; J C Yalowich; M K Ritke; D A Gewirtz
Journal:  Mol Pharmacol       Date:  1994-04       Impact factor: 4.436

Review 8.  Translation of new cancer treatments from pet dogs to humans.

Authors:  Melissa Paoloni; Chand Khanna
Journal:  Nat Rev Cancer       Date:  2008-02       Impact factor: 60.716

Review 9.  Mechanisms of anticancer drug resistance.

Authors:  Philip J Bergman
Journal:  Vet Clin North Am Small Anim Pract       Date:  2003-05       Impact factor: 2.093

Review 10.  Nanoparticle therapeutics: an emerging treatment modality for cancer.

Authors:  Mark E Davis; Zhuo Georgia Chen; Dong M Shin
Journal:  Nat Rev Drug Discov       Date:  2008-09       Impact factor: 84.694

View more
  7 in total

1.  Shenmai injection enhances the cytotoxicity of chemotherapeutic drugs against colorectal cancers via improving their subcellular distribution.

Authors:  Wen-Yue Liu; Jing-Wei Zhang; Xue-Quan Yao; Chao Jiang; Ji-Chao He; Pin Ni; Jia-Li Liu; Qian-Ying Chen; Qing-Ran Li; Xiao-Jie Zang; Lan Yao; Ya-Zhong Liu; Mu-Lan Wang; Pei-Qiang Shen; Guang-Ji Wang; Fang Zhou
Journal:  Acta Pharmacol Sin       Date:  2016-11-21       Impact factor: 6.150

2.  A clinical trial of super-stable homogeneous lipiodol-nanoICG formulation-guided precise fluorescent laparoscopic hepatocellular carcinoma resection.

Authors:  Pan He; Yongfu Xiong; Jinfa Ye; Biaoqi Chen; Hongwei Cheng; Hao Liu; Yating Zheng; Chengchao Chu; Jingsong Mao; Aizheng Chen; Yang Zhang; Jingdong Li; Jie Tian; Gang Liu
Journal:  J Nanobiotechnology       Date:  2022-06-03       Impact factor: 9.429

3.  Cholesterol-Modified Amino-Pullulan Nanoparticles as a Drug Carrier: Comparative Study of Cholesterol-Modified Carboxyethyl Pullulan and Pullulan Nanoparticles.

Authors:  Xiaojun Tao; Yongchao Xie; Qiufang Zhang; Ximin Qiu; Liming Yuan; Yi Wen; Min Li; Xiaoping Yang; Ting Tao; Minghui Xie; Yanwei Lv; Qinyi Wang; Xing Feng
Journal:  Nanomaterials (Basel)       Date:  2016-09-08       Impact factor: 5.076

4.  Effects of Particle Hydrophobicity, Surface Charge, Media pH Value and Complexation with Human Serum Albumin on Drug Release Behavior of Mitoxantrone-Loaded Pullulan Nanoparticles.

Authors:  Xiaojun Tao; Shu Jin; Dehong Wu; Kai Ling; Liming Yuan; Pingfa Lin; Yongchao Xie; Xiaoping Yang
Journal:  Nanomaterials (Basel)       Date:  2015-12-25       Impact factor: 5.076

5.  A super-stable homogeneous Lipiodol-hydrophilic chemodrug formulation for treatment of hepatocellular carcinoma.

Authors:  Pan He; En Ren; Biaoqi Chen; Hu Chen; Hongwei Cheng; Xing Gao; Xiaoliu Liang; Hao Liu; Jingdong Li; Bo Li; Aizheng Chen; Chengchao Chu; Xiaoyuan Chen; Jingsong Mao; Yang Zhang; Gang Liu
Journal:  Theranostics       Date:  2022-01-24       Impact factor: 11.556

6.  High efficacy of tamoxifen-loaded L-lysine coated magnetic iron oxide nanoparticles in cell cycle arrest and anti-cancer activity for breast cancer therapy.

Authors:  Soheila Rostami; Farzaneh Tafvizi; Hamid Reza Kheiri Manjili
Journal:  Bioimpacts       Date:  2021-12-01

7.  Targeted therapeutic nanotubes influence the viscoelasticity of cancer cells to overcome drug resistance.

Authors:  Ashwinkumar A Bhirde; Bhaskara V Chikkaveeraiah; Avinash Srivatsan; Gang Niu; Albert J Jin; Ankur Kapoor; Zhe Wang; Sachin Patel; Vyomesh Patel; Alexander M Gorbach; Richard D Leapman; J Silvio Gutkind; Angela R Hight Walker; Xiaoyuan Chen
Journal:  ACS Nano       Date:  2014-04-11       Impact factor: 15.881

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.